Immunity to heat shock proteins and pregnancy outcome. by Witkin, S S
Infectious Diseases in Obstetrics and Gynecology 7:35-38 (1999)
(C) 1999 Wiley-Liss, Inc.
Immunity to Heat Shock Proteins and
Pregnancy Outcome
S.S. Witkin*
Division ofImmunology and Infectious Diseases, Department of Obstetrics and Gynecology, Wei//
Medical College of Cornell University, New York, NY
ABSTRACT
Heat shock proteins are among the first proteins produced by the zygote after fertilization. In
addition, the maternal decidua also expresses heat shock proteins during the early stages of preg-
nancy. Autoimmunity to heat shock proteins is not typically evident in healthy women of repro-
ductive age. However, a chronic microbial infection, such as an asymptomatic Chlamydia tracho-
matis upper genital tract infection, results in prolonged exposure of the immune system to the
microbial 60 kDa heat shock protein (hsp60). This may result in immunity to conserved hsp60
epitopes and subsequent autoimmunity to selfhsp60. Women undergoing in vitro fertilization (IVF)
who never realized they had a chlamydial infection but who were positive for cervical anti-
chlamydial immunoglobulin A (IgA) antibodies had a much lower pregnancy rate than did women
who were negative for these antibodies. Furthermore, cervical IgA antibodies to the chlamydial
hsp60, as well as to a synthetic peptide corresponding to an hsp60 epitope present in both the
chlamydial and human hsp60, also correlated with IVF failure. In vitro incubation of newly fer-
tilized human embryos in medium containing maternal serum was shown to be deleterious to
embryo development if the sera was positive for antibodies reactive with human hsp60. In another
study, the ability of human hsp60 to elicit a lymphocyte proliferative response (cell-mediated im-
munity) correlated with a history of spontaneous early stage pregnancy loss. Thus, autoimmunity
to hsp60 might increase susceptibility to early stage pregnancy loss. Infect. Dis. Obstet. Gynecol.
7:35-38, 1999. (C) 1999 Wiley-Liss, Inc.
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he 60 kDa heat shock protein (hsp60) is a
highly conserved protein present in organisms
ranging from bacteria to plants to fruit flies to man.
It functions as a molecular intracellular chaperone,
transporting peptides within the cell and prevent-
ing incorrect polypeptide folding and denaturation.
The hsp60 molecule has not changed much during
evolution; the bacterial and human proteins share
almost a 50% amino acid sequence homology.
Despite this high degree of conservation, hsp60
is a dominant immunogen of most pathogenic bac-
teria. Perhaps this is due to the fact that the syn-
thesis of bacterial hsp60 is greatly upregulated dur-
ing infection, resulting in hsp60 becoming one of
the most prevalent microbial proteins. Immunity
following infection is typically confined to mi-
crobe-specific epitopes of the hsp60 molecule.
However, prolonged and/or repeated exposure to
microbial hsp60, or concomitant exposure to both
the microbial and human hsp60, could result in
immunity to conserved regions of the hsp60 mol-
ecule.
Heat shock proteins, including hsp60, are also
expressed during the early stages of pregnancy in
both the embryoz and maternal decidua.3 Termi-
nation of the pregnancy at this early stage may
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expose complexes of hsp60 and paternal antigens
to the immune system, resulting in induction of
hsp60-directed autoimmunity. Women with breast
cancer frequently develop autoantibodies to heat
shock proteins due to exposure of heat shock pro-
tein-tumor antigen complexes to the immune sys-
tem.4
We have been examining the relation between
autoimmunity to hsp60 and pregnancy outcome
and summarize our findings to date in this report.
ASYMPTOMATIC CHLAMYDIA TRACHOMATIS
GENITAL TRACT INFECTIONS, IMMUNITY
TO HSP60, AND PREGNANCY OUTCOME
AFTER IN VITRO FERTILIZATION
Chlamydia trachomatis infections of the female geni-
tal tract, the major cause of infertility due to oc-
cluded fallopian tubes, are often asymptomatic
and, therefore, undetected,s Being an obligate in-
tracellular parasite, C. trachomatis is able to evade
immune defense mechanisms and remain viable
within host cells for long periods of time.6 In vitro,
cells chronically infected with C. trachomatis syn-
thesize low levels of structural components but
continue to produce hsp60 at high levels. 7 Thus, in
women with an asymptomatic and untreated chla-
mydial infection that leads to tubal infertility, there
is long-term exposure to chlamydial hsp60. In ad-
dition, the local inflammatory response may elicit
synthesis of host hsp60. It has been hypothesized
that prolonged exposure to the immune system of
chlamydial hsp60 and/or concomitant exposure to
both the chlamydial and human hsp60 may lead to
hsp60 autoantibody formation.8-1 Since many
women with occluded fallopian tubes now seek to
become pregnant via in vitro fertilization (IVF), we
examined whether immunity to the chlamydial
hsp60 and human hsp60 would interfere with a
successful outcome.
In our initial study, endoccrvical specimens ob-
tained from 216 women at the time of oocyte aspi-
ration were tested for immunoglobulin A (IgA) an-
tibodies to C. trachomatis and to chlamydial
hsp60.1 None of these women ever had a recog-
nized C. trachomatis infection. Among the 34.3% of
women who subsequently delivered healthy in-
fants, only five (7.3%) were positive for cervical
anti-chlamydial hsp60 IgA, and one (1.5%) had IgA
antibodies to chlamydial structural components. In
contrast, among the 130 women whose embryo
transfers did not result in a term pregnancy, 27.7%
had anti-chlamydial hsp60 IgA, and 18.5% were
positive for antibodies to other chlamydial anti-
gens. Interestingly, while the majority of women
with antibodies to chlamydial structural antigens
were also hsp60-antibody positive, only 35% of
women with IgA anti-hsp60 were also positive
for antibodies to other chlamydial components.
This suggested that the chlamydial hsp60 was the
dominant immunogen in many of these infertile
women.
In subsequent evaluations, 122 of the above IVF
subjects were evaluated for cervical IgA antibodies
to synthetic peptides corresponding to unique or
conserved epitopes of the chlamydial hsp60,s An-
tibodies to a single epitope, corresponding to
amino acids 260-271 in the chlamydial hsp60, were
found to be immunodominant in our subjects. This
epitope is present in both the chlamydial and hu-
man hsp60, le Furthermore, antibodies to this epi-
tope correlated with the occurrence of a transient
"biochemical" pregnancy followed by embryo loss.
Biochemical pregnancies were detected in 22.2%
of women with anti-hsp60 IgA, as opposed to only
7.4% of women without anti-hsp60 IgA. Thus,
genital tract antibodies to a conserved region of
hsp60 in women with previously undetected expo-
sure to C. trachomatis was associated with early
stage pregnancy failure after embryo transfer in
women undergoing IVF.
In a third study, the detection of IgA antibodies
to C. trachomatis in follicular fluids of women un-
dergoing IVF were correlated with the presence of
human hsp60 antigen in these fluids. 13 All women
positive for human hsp60 had tubal infertility and
failed to become pregnant in their IVF cycle. This
documented that human hsp60 was expressed in
some women with C. trachomatis-associated tubal
infertility.
IMMUNITY TO CONSERVED HSP60
EPITOPE 260-271 IN WOMEN WITH C.
TRACHOMATIS-ASSOCIATED FALLOPIAN
TUBE OCCLUSION OR
ECTOPIC PREGNANCY
The association between chlamydial associated in-
fertility and immunity to conserved hsp60 epitope
260-271 was further examined in patients from
Hungary,4 Sweden,s and France.6 In each study,
antibodies to this conserved peptide were associ-
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ated with high-titer antibody to chlamydial surface
antigens and to salpingitis. Furthermore, antibod-
ies to the chlamydial hsp60 epitope were associated
with antibodies to human hsp60. In contrast, de-
tection of antibodies to the hsp60 of Escherichia coli
was not related to the presence of anti-human
hsp60 immunoglobulin G (IgG). 16 These studies
further support the suggestion that C. trachomatis
upper genital tract infections can result in sensiti-
zation to self-hsp60 epitopes in some women and,
furthermore, that this immunity is related to the
development of infertility.
ANTIBODIES TO HUMAN HSP60
AND INFERTILITY
Cervical samples from 91 women with primary or
secondary infertility and from women not trying to
conceive or who were fertile were analyzed for IgA
antibodies reactive with the recombinant human
hsp60.8 Detection of these antibodies was highly
associated with primary infertility (P 0.003). Fur-
thermore, cervical IgA anti-human hsp60 was re-
lated to detection of the pro-inflammatory cyto-
kines interferon-/ and tumor necrosis factor-a in
the cervix. Conversely, there was no relation be-
tween antibodies to hsp60 and detection of the
anti-inflammatory cytokine interleukin-10 in the
cervix. This suggested that genital tract autoimmu-
nity to hsp60 was associated with a pro-inflam-
matory immune response. This may interfere with
immune regulatory mechanisms essential to pre-
vent rejection of the developing embryo.
A more direct effect of hsp60 autoantibodies on
embryo development was also identified. Prior to
embryo transfer to the uterus, in-vitro-fertilized
embryos are grown in vitro in medium that contains
the maternal serum. It was observed that there was
an association between arrested embryo develop-
ment in vitro and the presence in maternal serum
of autoantibodies reactive with human hsp60.17
Further evaluations using mouse embryos and
monoclonal antibodies to mammalian hsp60 dem-
onstrated that antibodies to hsp60 were associated
with impaired embryo development.8 This
strongly suggested that hsp60 was expressed on the
surface of the early embryo and might be a target
for autoantibodies.
In two studies from the United States8 and
France,6 circulating IgG antibodies to the human
hsp60 were shown to be associated with a history of
recurrent abortion. In contrast, circulating antibod-
ies to C. trachomatis surface components were not
associated with first-trimester pregnancy failure.
CELL-MEDIATED IMMUNITY TO HUMAN
HSP60 AND SPONTANEOUS ABORTIONS
Inflammation leading to immune rejection is typi-
cally cell-mediated. It was therefore of consider-
able interest to examine whether cell-mediated im-
munity to hsp60 was also related to pregnancy fail-
ure. Our study involved 110 female partners of
infertile couples who were undergoing IVF and 41
fertile control women. Peripheral blood mono-
nuclear cells (PBMC) were collected and assayed
for proliferative responses to the human hsp60 and
the E. coli hsp60.9 A lymphocyte proliferative re-
sponse to the human hsp60 was more prevalent in
the IVF patients (21.8%) than in the fertile controls
(7.3%, P < 0.05). In contrast, equivalent percent-
ages of fertile (31.7%) and infertile (29.1%) women
responded to the E. coli hsp60. Among the IVF
patients, cell-mediated immunity was associated
with a history of spontaneous abortion. Only 12%
of women with no history of spontaneous abor-
tionsmas opposed to 40.7% of women with at least
one spontaneous abortionmhad a positive PBMC
proliferative response to human hsp60 (P 0.003).
The relation between therapeutic abortion and im-
munity to hsp60 was also examined. In contrast to
the above results, there was no discernible relation
between a history of therapeutic abortion and a
cell-mediated immune response to human hsp60.
This lack of an association with induced abortion
strongly suggested that an active and prolonged
rejection process was necessary for development of
cell-mediated immunity to self hsp60. Hsp60
readily associates with other proteins, leading to
immunity to both molecules,z Therefore, pro-
longed exposure of the maternal immune system to
paternal antigen-hsp60 autoantigen complexes
from disrupted cells may be one mechanism lead-
ing to hsp60 autoimmunity. Alternatively, an infec-
tious event may be responsible for both spontane-
ous pregnancy termination and induction of hsp60
autoimmunity.
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